Drug Shortage Report for SANDOZ EZETIMIBE
Report ID | 187427 |
Drug Identification Number | 02416778 |
Brand name | SANDOZ EZETIMIBE |
Common or Proper name | EZETIMIBE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 TAB |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-03-20 |
Estimated end date | 2023-03-24 |
Actual end date | 2023-03-27 |
Shortage status | Resolved |
Updated date | 2023-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-28 | English | Compare |
v5 | 2023-03-27 | French | Compare |
v4 | 2023-03-27 | English | Compare |
v3 | 2023-03-21 | English | Compare |
v2 | 2023-03-20 | French | Compare |
v1 | 2023-03-20 | English | Compare |
Showing 1 to 6 of 6